Welcome to The Canadian Pharmacogenomics Network for Drug Safety (CPNDS)
Adverse drug reactions are a serious public health problem. The Canadian Pharmacogenomics Network for Drug Safety (CPNDS) aims to help solve the drug safety problem by developing genetic tests that predict which patients are at risk of a serious adverse drug reaction. This will allow doctors to prescribe drugs based on a patient’s genetic profile: the right drug at the right dose for each child. Genes determine how drugs are metabolized and whether a drug accumulates in the body in toxic amounts.
The Canadian Pharmacogenomics Network for Drug Safety is finding drug safety solutions. CPNDS researchers are based in all the major children’s hospitals across Canada and in the national research hub in Vancouver, British Columbia. The researchers are collecting patient DNA samples, analyzing genes, and comparing patient reactions to various medications.